Cynthia Mattia‐Goldberg

Author

Penn State Milton S. Hershey Medical Center

Also Known As

C Mattia-Goldberg, C. Mattia-Goldberg, C. Mattia‐Goldberg, Cynthia Mattia-Goldberg, Cynthia Mattia‐Goldberg, Cynthia Mattia-Goldberg

Publications

756

Citations

H-Index

Concepts

All Affiliations

Penn State Milton S. Hershey Medical Center Stanford University Diabetes & Endocrine Associates Abbott (United States)Abbott Fund

About

Cynthia Mattia‐Goldberg is an author at Penn State Milton S. Hershey Medical Center specializing in obstetrics, endocrinology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	197
2	Public Health	2	2	197
3	Endocrinology	2	2	197
4	Obstetrics	2	2	197
5	Biochemistry	1	1	10

Cynthia Mattia‐Goldberg

Publications

678

Citations

H-Index

Page 1

	Year	Citations
A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata Kristof Chwalisż, Lois Larsen, Cynthia Mattia‐Goldberg, Fertility and Sterility Uterine LeiomyomataHormonal ContraceptiveUterine FibroidsFertilityMedicine	2007	138
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution Robert J. Przybelski, Elaine K. Daily, James C. Kisicki, Critical Care Medicine	1996	137
Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious Puberty Peter A. Lee, Karen O. Klein, Nelly Mauras, The Journal of Clinical Endocrinology & Metabolism	2012	68
The effects of 1-month administration of asoprisnil (J867), a selective progesterone receptor modulator, in healthy premenopausal women Kristof Chwalisż, W. Elger, Therese Stickler, Human Reproduction	2005	61
Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery E. Kirk Neely, PeterA Lee, CliffordA Bloch, International Journal of Pediatric Endocrinology Tanner Breast StageFertilityHuman GrowthReproductive HealthNeuroendocrinology	2010	59
Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery E. Kirk Neely, Peter A. Lee, C Bloch, International Journal of Pediatric Endocrinology	2010	52
Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer Aaron Spitz, Jay M. Young, Lois Larsen, Prostate Cancer and Prostatic Diseases	2011	49
Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study Peter A. Lee, E. Kirk Neely, John S. Fuqua, International Journal of Pediatric Endocrinology	2011	47
Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials Elizabeth A. Stewart, Michael P. Diamond, Alistair Williams, Human Reproduction	2019	30
Absence of Immunogenicity of Diaspirin Cross-Linked Hemoglobin in Humans Mehul J. Patel, Edwin J. Webb, Tina E. Shelbourn, Blood	1998	17

Page 1